| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.17 | 0.006 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |